Chronic dementia in Parkinson's disease treated by...[Adv Neurol. 1993]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Adv Neurol. 1993;60:479-83.Links

Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.

Nishiyama K, Mizuno T, Sakuta M, Kurisaki H.

Department of Neurology, Japanese Red Cross Medical Center, Tokyo.

Reports about chronic-onset dementia due to ACA have been rare. Here we described five patients with chronic dementia induced by ACA. We examined their clinical aspect, neuropsychological aspect, and neuroradiological aspect in detail. Our study suggests the possibility of ACA-induced chronic-onset dementia in PD patients.

PMID: 8420174 [PubMed - indexed for MEDLINE]

[Chronic dementia in Parkinson disease treated by long-term administration of anticholinergic drug--evaluation of neuropsychological test, PET, and SPECT] [Rinsho Shinkeigaku. 1991]
Whole-brain voxel-based correlation analysis between regional cerebral blood flow and intelligence quotient score in Parkinson's disease. [Eur Neurol. 2004]
A retrospective analysis of the effects of anticholinergic medication on memory performance in Parkinson's disease. [J Neuropsychiatry Clin Neurosci. 1991]
ReviewrCBF SPECT in Parkinson's disease patients with mental dysfunction. [J Neural Transm Suppl. 1997]
ReviewUse of functional imaging in Parkinsonism and dementia. [Mov Disord. 2003]

Patient Drug Information

Trihexyphenidyl (Artane®, Artane Sequels®, Trihexane®, ...) Trihexyphenidyl is used to treat the symptoms of Parkinson's disease and tremors caused by other medical problems or drugs.

» read more ...

Display Show

Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.

Related Articles